Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 21, 2016 08:30 ET | Source: Keryx Biopharmaceuticals, Inc.

Keryx Biopharmaceuticals to Webcast its Presentation at Ladenburg Thalmann’s 2016 Healthcare Conference

BOSTON, Sept. 21, 2016 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc, (NASDAQ:KERX), a biopharmaceutical company focused on bringing innovative medicines to people with renal disease, today...
September 01, 2016 08:30 ET | Source: Keryx Biopharmaceuticals, Inc.

Keryx Biopharmaceuticals to Present at Two Upcoming Investor Healthcare Conferences

BOSTON, Sept. 01, 2016 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc, (NASDAQ:KERX), a biopharmaceutical company focused on bringing innovative medicines to people with renal disease, today...
August 01, 2016 07:30 ET | Source: Keryx Biopharmaceuticals, Inc.

Keryx Biopharmaceuticals Announces Interruption in Supply of Auryxia® (ferric citrate) and Second Quarter 2016 Financial Results

- Supply interruption does not affect the safety profile of currently available Auryxia -- Company withdraws its 2016 financial guidance -- Company to host conference call today at 8:30 a.m. EDT - ...
July 29, 2016 08:30 ET | Source: Keryx Biopharmaceuticals, Inc.

Keryx Biopharmaceuticals to Host Conference Call of Second Quarter 2016 Financial Results on Monday, August 1, 2016

BOSTON, July 29, 2016 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX), a biopharmaceutical company focused on bringing innovative medicines to people with renal disease, today...
June 27, 2016 08:00 ET | Source: Keryx Biopharmaceuticals, Inc.

Douglas Jermasek to Join Keryx Biopharmaceuticals as Vice President, Marketing and Strategy

BOSTON, June 27, 2016 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX), a biopharmaceutical company focused on bringing innovative medicines to people with renal disease, today...
June 21, 2016 08:00 ET | Source: Keryx Biopharmaceuticals, Inc.

Keryx Biopharmaceuticals Appoints Two New Board Members

BOSTON, June 21, 2016 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX), a biopharmaceutical company focused on bringing innovative medicines to people with renal disease, today...
June 14, 2016 08:30 ET | Source: Keryx Biopharmaceuticals, Inc.

Keryx Biopharmaceuticals to Present at JMP’s Life Science Conference on Tuesday, June 21

BOSTON, June 14, 2016 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc, (NASDAQ:KERX), a biopharmaceutical company focused on bringing innovative medicines to people with renal disease, today...
April 28, 2016 07:00 ET | Source: Keryx Biopharmaceuticals, Inc.

Keryx Biopharmaceuticals Announces First Quarter 2016 Financial Results

Company reported $6.8 million in first quarter total revenues, including $5.6 million of Auryxia™ (ferric citrate) net U.S. product sales2016 product sales and cash operating expense guidance...
April 14, 2016 08:30 ET | Source: Keryx Biopharmaceuticals, Inc.

Keryx Biopharmaceuticals to Host Conference Call of First Quarter 2016 Financial Results on Thursday, April 28, 2016

BOSTON, April 14, 2016 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX), a biopharmaceutical company focused on bringing innovative medicines to market for people with renal...
April 01, 2016 08:30 ET | Source: Keryx Biopharmaceuticals, Inc.

Keryx Biopharmaceuticals Announces New Appointments and Changes to its Board of Directors

BOSTON, April 01, 2016 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX), a biopharmaceutical company focused on bringing innovative medicines to market for people with renal...